Soler Juan José, Martínez-García Miguel Angel, Román Pilar, Orero Rosa, Terrazas Susana, Martínez-Pechuán Amparo
Unidad de Neumología, Servicio de Medicina Interna, Hospital General de Requena, Valencia, España.
Arch Bronconeumol. 2006 Oct;42(10):501-8. doi: 10.1016/s1579-2129(06)60576-4.
Patients with chronic obstructive pulmonary disease (COPD) and a history of frequent exacerbations are a target population of particular interest from both a clinical and an economic standpoint. The objective of this study was to evaluate the effectiveness of a program designed specifically to manage patients in this subgroup.
This was a 1-year randomized controlled trial designed to compare the effectiveness of a specific program (SP) with that of conventional management (CM) in a group of patients with a high frequency of exacerbations (3 or more per year). Within-group and between-group comparisons were carried out for a number of variables related to the patients medical care, dyspnea, health-related quality of life (HRQL), inhalation technique, and pulmonary function.
A total of 26 patients were enrolled in the study (all men). The mean (SD) age was 73 (8) years, and mean forced expiratory volume in 1 second (FEV1) expressed as a percentage of the reference value was 43% (15%). Exacerbations requiring hospital care (emergency department visits and/or admission) decreased in both groups: by 24.4% (P not significant) in the CM group and 44.1% (P=.061) in the SP group. Hospital admissions decreased 73.3% in the SP group and increased 22% in the CM group (P< .001). While length of hospital stay decreased 77.3% in the SP group, this figure almost doubled in the CM group (P=.014). Dyspnea, HRQL, and inhalation technique improved in both groups. FEV1 fell by 46 mL/year in the CM group and increased 10 mL/year in the SP group (P not significant).
The use of a simple program to manage selected patients with a history of frequent exacerbations produces a significant reduction in the number of hospital admissions, an improvement in HRQL, and may improve prognosis.
从临床和经济角度来看,慢性阻塞性肺疾病(COPD)且有频繁急性加重病史的患者是特别受关注的目标人群。本研究的目的是评估一个专门为管理该亚组患者而设计的项目的有效性。
这是一项为期1年的随机对照试验,旨在比较特定项目(SP)与传统管理(CM)对一组急性加重频繁(每年3次或更多)患者的有效性。对与患者医疗护理、呼吸困难、健康相关生活质量(HRQL)、吸入技术和肺功能相关的多个变量进行组内和组间比较。
共有26名患者纳入研究(均为男性)。平均(标准差)年龄为73(8)岁,1秒用力呼气容积(FEV1)占参考值的百分比平均为43%(15%)。两组中需要住院治疗的急性加重(急诊就诊和/或入院)均减少:CM组减少24.4%(P无统计学意义),SP组减少44.1%(P = 0.061)。SP组住院次数减少73.3%,CM组增加22%(P < 0.001)。虽然SP组住院时间减少77.3%,但CM组这一数字几乎翻倍(P = 0.014)。两组的呼吸困难、HRQL和吸入技术均有所改善。CM组FEV1每年下降46 mL,SP组每年增加10 mL(P无统计学意义)。
使用一个简单的项目来管理有频繁急性加重病史的特定患者,可显著减少住院次数,改善HRQL,并可能改善预后。